Literature DB >> 21729957

Seroprevalence of herpes simplex virus 2 among Hispanics in the USA: National Health and Nutrition Examination Survey, 2007-2008.

M Molina1, R A Romaguera, J Valentine, G Tao.   

Abstract

To examine the seroprevalence of herpes simplex virus type 2 (HSV-2) among Hispanics in the USA, we used the cross-sectional, nationally representative National Health and Nutrition Examination Survey to compare the seroprevalence of HSV-2 between Hispanic persons of Mexican heritage and non-Mexican heritage aged 14-44 years, from survey years 2007-2008. The overall HSV-2 seroprevalence among Hispanics aged 14-44 years was 17.5% (95% confidence interval [CI], 15.2, 20.1) in the USA. HSV-2 seroprevalence was significantly lower among Mexican Americans than among other Hispanics (11.7% vs. 27.8%, P < 0.01). Prevalence of HSV-2 was also significantly associated with gender and age. The significant difference in HSV-2 seroprevalence between Hispanic persons of Mexican heritage and non-Mexican heritage suggested that targeting specific subgroups of Hispanics for preventive interventions may be a strategy to reduce the transmission of HSV-2 and HIV among Hispanics in the USA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21729957     DOI: 10.1258/ijsa.2011.010474

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

1.  Behavioral, Psychological, Gender, and Health Service Correlates to Herpes Simplex Virus Type 2 Infection among Young Adult Mexican-American Women Living in a Disadvantaged Community.

Authors:  Kathryn M Nowotny; Jessica Frankeberger; Victoria E Rodriguez; Avelardo Valdez; Alice Cepeda
Journal:  Behav Med       Date:  2018-05-09       Impact factor: 3.104

2.  Dual TLR2/9 Recognition of Herpes Simplex Virus Infection Is Required for Recruitment and Activation of Monocytes and NK Cells and Restriction of Viral Dissemination to the Central Nervous System.

Authors:  Erdenebileg Uyangaa; Jin Young Choi; Ajit Mahadev Patil; Ferdaus Mohd Altaf Hossain; Sung Ok Park; Bumseok Kim; Koanhoi Kim; Seong Kug Eo
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.